Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic

    Somatic mutations in p53, which inactivate the tumour-suppressor function of p53 and often confer oncogenic gain-of-function properties, are very common in cancer1,2. Here we studied the effects of hotspot gain-o...

    Eliran Kadosh, Irit Snir-Alkalay, Avanthika Venkatachalam, Shahaf May in Nature (2020)

  2. Article

    Open Access

    Widespread parainflammation in human cancer

    Chronic inflammation has been recognized as one of the hallmarks of cancer. We recently showed that parainflammation, a unique variant of inflammation between homeostasis and chronic inflammation, strongly pro...

    Dvir Aran, Audrey Lasry, Adar Zinger, Moshe Biton, Eli Pikarsky in Genome Biology (2016)

  3. No Access

    Article

    Inflammatory networks underlying colorectal cancer

    Inflammation is one of the hallmarks of cancer. Ben-Neriah and colleagues review the inflammatory networks underlying colorectal cancer.

    Audrey Lasry, Adar Zinger, Yinon Ben-Neriah in Nature Immunology (2016)

  4. No Access

    Article

    Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

    Ectopic lymphoid structures develop at sites of chronic inflammation and are generally thought to be beneficial in the control of cancer. Pikarsky and colleagues show that these structures can instead nurture ...

    Shlomi Finkin, Detian Yuan, Ilan Stein, Koji Taniguchi, Achim Weber in Nature Immunology (2015)

  5. No Access

    Article

    Inflammation meets cancer, with NF-κB as the matchmaker

    Inflammation is a fundamental protective response that sometimes goes awry and becomes a major cofactor in the pathogenesis of many chronic human diseases, including cancer. Here we review the evolutionary rel...

    Yinon Ben-Neriah, Michael Karin in Nature Immunology (2011)

  6. No Access

    Article

    Epithelial microRNAs regulate gut mucosal immunity via epithelium–T cell crosstalk

    Normal gut–immune system homeostasis requires interactions among epithelial cells, lymphocytes and host microflora. Ben-Neriah and colleagues show that defined microRNA expression in the gut mucosa is also imp...

    Moshe Biton, Avi Levin, Michal Slyper, Irit Alkalay, Elad Horwitz in Nature Immunology (2011)

  7. No Access

    Article

    CKIα ablation highlights a critical role for p53 in invasiveness control

    In a mouse model of intestinal cancer, Yinon Ben-Neriah and colleagues show that in the absence of CK1-α, the loss of p53 dramatically enhances tumour progression and metastasis. The tumour repressor p53 norma...

    Ela Elyada, Ariel Pribluda, Robert E. Goldstein, Yael Morgenstern, Guy Brachya in Nature (2011)

  8. No Access

    Chapter and Conference Paper

    Design and Synthesis of Backbone Cyclic Phosphopeptides: The IκB Model

    Nir Qvit, Ada Hatzubai, Deborah E. Shalev, Yinon Ben-Neriah in Peptides for Youth (2009)

  9. No Access

    Article

    Epithelial NF-κB maintains host gut microflora homeostasis

    Epithelial NF-κB preserves the integrity of the gut epithelial barrier and coordinates the antimicrobial actions of the innate and adaptive immune systems. Deficiency in or hyperactivation of this transcriptio...

    Yinon Ben-Neriah, Marc Schmidt-Supprian in Nature Immunology (2007)

  10. No Access

    Article

    Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells

    The mechanisms by which commensal bacteria suppress inflammatory signalling in the gut are still unclear. Here, we present a cellular mechanism whereby the polarity of intestinal epithelial cells (IECs) has a ...

    Jongdae Lee, Ji-Hun Mo, Kyoko Katakura, Irit Alkalay, Adam N. Rucker in Nature Cell Biology (2006)

  11. No Access

    Article

    NF-κB functions as a tumour promoter in inflammation-associated cancer

    The causes of sporadic human cancer are seldom recognized, but it is estimated that carcinogen exposure and chronic inflammation are two important underlying conditions for tumour development, the latter accou...

    Eli Pikarsky, Rinnat M. Porat, Ilan Stein, Rinat Abramovitch, Sharon Amit in Nature (2004)

  12. No Access

    Article

    Behind the scenes of anergy: a tale of three E3s

    Anergy induction initiates a transcription program involving the upregulation of several ubiquitin ligases (E3s). New data show how these E3s contribute to the establishment of anergy.

    Matti Davis, Yinon Ben-Neriah in Nature Immunology (2004)

  13. No Access

    Article

    Regulatory functions of ubiquitination in the immune system

    Protein modification via covalent attachment of ubiquitin has emerged as one of the most common regulatory processes in all eukaryotes; it is possibly second only to phosphorylation. In fact, ubiquitination and p...

    Yinon Ben-Neriah in Nature Immunology (2002)

  14. No Access

    Article

    High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation

    Based on the essential involvement of NF-κB in immune and inflammatory responses and its apoptosis-rescue function in normal and malignant cells, inhibitors of this transcription factor are potential therapeut...

    Iris Lavon, Iris Goldberg, Sharon Amit, Limor Landsman, Steffen Jung in Nature Medicine (2000)

  15. No Access

    Article

    Identification of the receptor component of the IκBα–ubiquitin ligase

    NF-κB, a ubiquitous, inducible transcription factor involved in immune, inflammatory, stress and developmental processes, is retained in a latent form in the cytoplasm of non-stimulated cells by inhibitory mol...

    Avraham Yaron, Ada Hatzubai, Matti Davis, Iris Lavon, Sharon Amit in Nature (1998)

  16. No Access

    Article

    Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB

    INDUCIBLE gene expression in eukaryotes is mainly controlled by the activity of transcriptional activator proteins, such as NF-κB (refs 1–3), a factor activated upon treatment of cells with phorbolesters, lipo...

    Thomas Henkel, Thomas Machleidt, Irit Alkalay, Martin Krönke, Yinon Ben-Neriah in Nature (1993)

  17. No Access

    Article

    Leukocytes express a novel gene encoding a putative transmembrane protein-kinase devoid of an extracellular domain

    Tyrosine-specific phosphorylation of proteins is a key to the control of diverse pathways leading to cell growth and differentiation1. The protein-tyrosine kinases described to date are either transmembrane prote...

    Yinon Ben-Neriah, Asne R. Bauskin in Nature (1988)

  18. No Access

    Article

    Isolation and expression of a complementary DNA that confers multidrug resistance

    The emergence and outgrowth of a population of tumour cells resistant to multiple drugs is a major problem in the chemotherapeutic treatment of cancer. We have used highly drug-resistant cell lines developed in v...

    Philippe Gros, Yinon Ben Neriah, James M. Croop, David E. Housman in Nature (1986)

  19. No Access

    Chapter and Conference Paper

    Structural Modification of c-abl in Lymphoma and Leukemia

    Vertebrate DNA contains a gene, named c-abl, that was disclosed by a rapidly oncogenic retrovirus, Abelson murine leukemia virus (A-MuLV)- A-MuLV carries a portion of c-abl (Goff et al., 1980) including a region ...

    Yinon Ben-Neriah, David Baltimore in Mechanisms in B-Cell Neoplasia (1986)

  20. No Access

    Chapter

    Normal and Transforming N-Terminal Variants of c-abl

    V-abl was first described as the oncogene contained in Abelson murine leukemia virus (A-MuLV), a virus that transforms both lymphocytes and fibroblast lines. The v-abl gene product has a pro...

    Yinon Ben-Neriah, David Baltimore in Oncogenes and Growth Control (1986)

previous disabled Page of 2